https://orcid.org/0000-0003-2850-6209
References
- Alijotas-Reig J, Fernández-Figueras MT, Puig L. Late-onset inflammatory adverse reactions related to soft tissue filler injections. Clin Rev Allergy Immunol. 2013;45:97–108. doi:https://doi.org/10.1007/s12016-012-8348-5.
- Humphrey S, Jones DH, Carruthers JD, Carruthers A, Beleznay K, Wesley N, Black JM, Vanderveen S, Minokadeh A. Retrospective review of delayed adverse events secondary to treatment with a smooth, cohesive 20-mg/mL hyaluronic acid filler in 4500 patients. J Am Acad Dermatol. 2020;83:86–95. doi:https://doi.org/10.1016/j.jaad.2020.01.066.
- Rzany B, DeLorenzi C. Understanding, avoiding, and managing severe filler complications. Plast Reconstr Surg. 2015;136:196S–203S. doi:https://doi.org/10.1097/PRS.0000000000001760.
- Chiang YZ, Pierone G, Al-Niaimi F. Dermal fillers: pathophysiology, prevention and treatment of complications. J Eur Acad Dermatol Venereol. 2017;31:405–13. doi:https://doi.org/10.1111/jdv.13977.
- Alijotas-Reig J, Garcia-Gimenez V. Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinicalfindings, longterm follow-up and review of the literature. J Eur Acad Dermatol Venereol. 2008;22:150–61.
- Sadeghpour M, Quatrano NA, Bonati LM, Arndt KA, Dover JS, Kaminer MS. Delayed-onset nodules to differentially crosslinked hyaluronic acids: comparative incidence and risk assessment. Dermatol Surg. 2019;45:1085–94. doi:https://doi.org/10.1097/DSS.0000000000001814.
- Artzi O, Loizides C, Verner I, Landau M. Resistant and recurrent late reaction to hyaluronic acid–based gel. Dermatol Surg. 2016;42:31–37. doi:https://doi.org/10.1097/DSS.0000000000000562.
- Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable non-animal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg. 2002;28:491–94.
- Coleman SR. Cross-linked hyaluronic acid fillers. Plast Reconstr Surg. 2006;117:661–65. doi:https://doi.org/10.1097/01.prs.0000200913.34368.79.
- De Boulle K, Heydenrych I. Patient factors influencing dermal filler complications: prevention, assessment, and treatment. Clin Cosmet Invest Dermatol. 2015;8:205–14. doi:https://doi.org/10.2147/CCID.S80446.
- Lemperle G, Gauthier-Hazan N, Wolters M, Eisemann-Klein M, Zimmermann U, Duffy DM.Foreign body granulomas after all injectable dermal fillers: part 1. Possible causes. Plast Reconstr Surg 2009;123(6):1842–63. doi:https://doi.org/10.1097/PRS.0b013e31818236d7.
- Guduk SS. An unusual delayed type reaction following periorbital filler injection with hyaluronic acid. Aesthet Surg J. 2018;38:109–13. doi:https://doi.org/10.1093/asj/sjy035.
- Munavalli GG, Knutsen-Larson S, Lupo MP, Geronemus RG. Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II-induced cutaneous inflammation. JAAD Case Rep. 2021;10:63–68. doi:https://doi.org/10.1016/j.jdcr.2021.02.018.
- Yang J, Petitjean SJL, Koehler M, Zhang Q, Dumitru AC, Chen W, Derclaye S, Vincent SP, Soumillion P, Alsteens D. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun. 2020;11:4541. doi:https://doi.org/10.1038/s41467-020-18319-6.
- FDA Briefing Document. Moderna COVID-19 Vaccine. Vaccines and related biological products advisory committee meeting; December 17, 2020. [accessed 2021 January 10. https://www.fda.gov/media/144434/download.
- Artzi O, Cohen JL, Dover JS, Suwanchinda A, Pavicic T, Landau M, Goodman GJ, Ghannam S, Al Niaimi F, van Loghem JAJ, et al. Delayed inflammatory reactions to hyaluronic acid fillers: a literature review and proposed treatment algorithm. Clin Cosmet Investig Dermatol. 2020;13:371–78. doi:https://doi.org/10.2147/CCID.S247171.
- Leung YY, Yao Hui LL, Kraus VB. Colchicine- Update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum. 2015;45:341–50. doi:https://doi.org/10.1016/j.semarthrit.2015.06.013.
- Nuki G. Colchicine: its mechanism of action and efficacy in crystal-induced inflammation. Curr Rheumatol Rep. 2008;10:218–27. doi:https://doi.org/10.1007/s11926-008-0036-3.
- Dalbeth N, Lauterio TJ, Wolfe HR. Mechanism of action of colchicine in the treatment of gout. Clin Ther. 2014;36:1465–79. doi:https://doi.org/10.1016/j.clinthera.2014.07.017.
- Cocco G, Chu DC, Pandolfi S. Colchicine in clinical medicine. A guide for internists. Eur J Intern Med 2010;21:503–08. doi:https://doi.org/10.1016/j.ejim.2010.09.010.
- Aivaliotis M, Kontochristopoulos G, Hatziolou E, Aroni K, Zakopoulou N. Successful colchicine administration in facial granulomas caused by cosmetic implants: report of a case. J Dermatolog Treat. 2007;18:112–14. doi:https://doi.org/10.1080/08910600601149619.